Compare Bundamedik Tbk (BMHS) vs Reksa Dana Indeks Mandiri ETF LQ45 (XMLF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bundamedik Tbk vs Reksa Dana Indeks Mandiri ETF LQ45 — how do they compare? Bundamedik Tbk trades at Rp189 (market cap 1.62T, 35.7K 24h volume), while Reksa Dana Indeks Mandiri ETF LQ45 trades at Rp725 (market cap 9.29B, 700 24h volume). The key difference: Bundamedik Tbk is far larger — about 174.4× Reksa Dana Indeks Mandiri ETF LQ45's market cap, and Bundamedik Tbk is more actively traded (35.7K versus 700). Which is the better fit depends on your goals.
| BMHS | XMLF | |
|---|---|---|
Market Cap | 1.62T | 9.29B |
Volume | 35.7K | 700 |
Lot | 357 | 7 |
Turnover | 6.77M | 507.5K |
Average Price | 189.63 | 725 |
Value | 6.77M | 507.5K |
Indicative Equilibrium Price | 190 | — |
Indicative Equilibrium Volume | 52 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bundamedik Tbk
PT Bundamedik Tbk (the “Company”) was established on 13 April 1978 based on Notarial Deed No. 21 of Adlan Yulizar, S.H. The Company strated its commercial operations in 1978. The Company’s parent and ultimate parent of the group is PT Bunda Investama Indonesia.
Read more on BMHS →
